A phase I study of cabozantinib plus nivolumab (CaboNivo) in patients (pts) refractory metastatic urothelial carcinoma (mUC) and other genitourinary (GU) tumors

Andrea B. Apolo, Amir Mortazavi, Mark N. Stein, Sharmistha Pal, Nicole N. Davarpanah, Howard L. Parnes, Y. Ning, Deneise C Francis, Lisa M. Cordes, Marilise Anne Berniger,

Annals of Oncology · 2016 · 13 citations · 0 references

DOIFull text

Open access

Concepts